Eli Lilly | LLY - Efectivo Y Equivalentes

Precio De Mercado
934.60
Cambio Diario
83.39 9.80%
Mensual
1.61%
Anual
17.69%
Q2 Expectativa
865.04




Efectivo Y Equivalentes Cambio Fecha
AbbVie USD 5.23B 400M 2025-12
Abbott USD 6.8B 1.72B 2026-03
ALKERMES USD 388.57M 227.88M 2025-12
Amgen USD 9.13B 316M 2025-12
AstraZeneca USD 7.56B 1.85B 2026-03
Baxter International USD 2.02B 51M 2026-03
Biogen USD 3.38B 374.2M 2026-03
Bristol-Myers Squibb USD 9.57B 635M 2026-03
Coherus Biosciences USD 88.88M 14.47M 2025-12
Drreddys Laboratories INR 18.66B 9.65B 2025-12
Eli Lilly USD 5.28B 1.99B 2026-03
Gilead Sciences USD 7.56B 234M 2025-12
GlaxoSmithKline GBP 3.44B 292M 2026-03
Glaxosmithkline GBP 3.3B 303M 2025-09
J&J USD 21.69B 1.98B 2026-03
Medtronic USD 1.15B 135M 2025-12
Merck USD 14.57B 3.6B 2025-12
Neurocrine Biosciences USD 713M 372.8M 2025-12
Novartis USD 11.44B 1.88B 2025-12
Novartis USD 9.56B 2.9B 2025-09
Novo Nordisk A/S DKK 18.44B 5.78B 2025-06
Perrigo USD 432.1M 22.1M 2025-09
Pfizer USD 1.34B 295M 2025-09
Phibro Animal Health USD 55.49M 17.28M 2025-12
Prestige Brands USD 62.37M 56.73M 2025-12
Regeneron Pharmaceuticals USD 2.96B 15.9B 2026-03
Roche Holding CHF 7.55B 579M 2025-06
Sanofi EUR 7.66B 1.25B 2025-12
Sanofi EUR 7.66B 1.25B 2025-12
United Therapeutics USD 1.56B 217M 2025-12
Zoetis USD 2.08B 649M 2025-09